LPLucia Pinilla

Lucia Pinilla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucia Pinilla has a total of 139 co-authors. Here are the top co-authors by number of shared publications:

  • Bastien Lechat

    Flinders Health and Medical Research Institute: Sleep Health, College of Medicine and Public Health, Flinders University, Adelaide, Australia

    8 shared publications
  • Danny Joel Eckert

    Flinders Health and Medical Research Institute: Sleep Health, College of Medicine and Public Health, Flinders University, Adelaide, Australia

    8 shared publications
  • Peter G. Catcheside

    Adelaide Institute for Sleep Health and FHMRI Sleep Health, College of Medicine and Public Health, Flinders University, Adelaide, Australia

    7 shared publications
  • Hannah Scott

    Flinders Health and Medical Research Institute: Sleep Health, Flinders University , Adelaide, South Australia

    6 shared publications
  • Duc Phuc Nguyen

    5 shared publications
  • Manuel Sánchez-De-La-Torre

    Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), 28029, Madrid, Spain; Instituto de Investigación Sanitaria Castilla La Mancha (IDISCAM), 45071, Toledo, Spain; Department of Nursing, Physiotherapy and Occupational Therapy. Faculty of Physiotherapy and Nursing. Universidad de Castilla la Mancha, 45071, Toledo, Spain

    5 shared publications

Latest Publications

  • Open Access

    Evaluating the effectiveness of vestibular and ocular motor function assessments in detecting driver sleepiness: A protocol paper

    by Alisha Guyett, Claire Dunbar, Nicole Lovato, Katrina Nguyen, Kelsey Bickley, Duc Phuc Nguyen, Amy Reynolds, Maslin Hughes, Hannah Scott, Robert Adams, et al.

  • Open Access

    High night-to-night variability in obstructive sleep apnea severity is associated with prevalent cardiovascular disease

    by Bastien Lechat, Lucía Pinilla, Kelly Sansom, Andrew Vakulin, Pierre Escourrou, Jean-Louis Pépin, Sébastien Bailly, Sébastien Baillieul, Amy C Reynolds, Hannah Scott, et al.

    Study Objectives: High night-to-night variability in obstructive sleep apnea (OSA) severity is associated with cardiovascular risk factors such as high blood pressure and pulse wave velocity, yet associations with cardiovascular events remain unknown. This study investigates the association of multi-night OSA severity and night-to-night variability with the prevalence of non-fatal major adverse cardiovascular and cerebrovascular events (MACCEs). Materials and Methods: Multi-night data were collected from people who purchased and used an FDA-cleared under-mattress sensor to track nightly OSA severity (apnea-hypopnea index; AHI) and completed questionnaires on physician-diagnosed health conditions between 10/2022–12/2024. Mean OSA severity and variability (AHI standard deviation) were calculated over 6 months preceding questionnaire data collection. The primary outcome was a composite of non-fatal MACCEs, including myocardial infarction or heart attack, stroke, angina pectoris or coronary artery disease, and congestive heart failure. Logistic models assessed associations of OSA severity and variability with MACCE prevalence. Results: Among 3,159 participants (19% female, aged 49 ± 13 years, BMI of 29 ± 6 kg/m2), 142 (4.5%) MACCE cases were reported. Participants with moderate–severe OSA had higher odds of MACCEs versus those without OSA (OR [95%CI]; 1.45 [0.93, 2.25]). High night-to-night OSA variability (75th vs. 25th percentile; 8.0 vs. 2.8 events/h) was associated with 34% higher odds of having a MACCE, independent of OSA severity and other confounders (1.34 [1.04, 1.72]). Conclusions: High night-to-night variability in OSA severity is associated with higher odds of non-fatal MACCEs. These novel findings underscore the need for prospective trials to investigate the potential causal mechanisms between variability in OSA severity and incident cardiovascular events.


  • Open Access

    Evaluating the effectiveness of vestibular and ocular motor function assessments in detecting driver sleepiness: A Protocol Paper

    by Alisha Guyett, Claire Dunbar, Nicole Lovato, Katrina Nguyen, Kelsey Bickley, Phuc Nguyen, Amy Reynolds, Maslin Hughes, Hannah Scott, Robert Adams, et al.

    Background: Prolonged wakefulness, restricted sleep, and circadian factors can impact driving performance and road safety. Currently, there are no effective objective roadside tests to detect the state of driver sleepiness during or prior to driving, or predict future driving impairment risk. This paper reports on an extended wakefulness protocol used to determine if a portable virtual reality device to administer vestibular-ocular motor function (VOM) tests can effectively detect 1) driver state of sleepiness during or just prior to driving, and 2) predict trait sleepiness and future driving risk. Methods: Fifty healthy adults with regular sleep within 9pm to 8am were recruited for an experimental laboratory procedure which involved two phases: an initial overnight sleep study, and a subsequent period of extended wakefulness lasting ~29 hours. During the wakefulness phase, participants undertook neurobehavioural testing, a simulated driving test, and repeat assessments of VOM to establish if ocular markers can predict sleepiness state and sleepiness-related performance impairments (Trial registry ACTRN12621001610820). Discussion: This protocol outlined a study that aimed to establish the sensitivity of VOM test the effects of extended wakefulness and circadian phase on driver state and trait sleepiness and subsequent sleepiness-related driving impairment. Furthermore, the protocol aims to define the best VOM predictors to identify driver sleepiness state (road side testing and pre-drive assessments) and sleepiness trait (predicting future driving risk) to establish proof of concept for its potential application as a roadside, pre-drive and general sleepiness related fitness to drive test.

  • Open Access

    ACCESS-OSA: a randomized controlled trial for accurate, accessible, and cost-effective screening solutions for obstructive sleep apnoea: study protocol

    by Jack Manners, Maddy Roch, Lucia Pinilla, Robert J Adams, Barbara Toson, Ching Li Chai-Coetzer, Billingsley Kaambwa, Maree Barnes, Bastien Lechat, Kelly A Loffler, et al.

    Obstructive sleep apnoea (OSA) is common and burdensome, yet current diagnostic pathways remain costly and often misclassify patients. Single-night polysomnography (PSG), the diagnostic gold standard, fails to capture night-to-night variability in severity, is difficult to access and costly. Emerging technologies enable multi-night in-home evaluation, but robust comparative evidence regarding accuracy and cost-effectiveness is lacking. This study will evaluate (a) the diagnostic accuracy of three multi-night in-home devices versus conventional single night PSG; (b) the patient and signal characteristics that optimize diagnostic performance; and (c) the cost-effectiveness of these pathways for clinical implementation. We will conduct a three-arm randomized diagnostic strategy trial (n = 500) enrolling adults referred for suspected OSA over a recruitment period of several years from July 2025. All participants will undergo both conventional single-night PSG and multi-night assessment with an under-mattress sensor, oximetry ring, and forehead EEG device. Participants will be randomized to one of three diagnostic pathways, determining the order in which sleep physicians interpret test results. Sleep physicians will provide sequential diagnostic decisions at each stage, and a blinded expert panel will determine consensus diagnoses. The primary outcome is diagnostic accuracy of each pathway compared with consensus diagnosis. Secondary outcomes include cost-effectiveness, patient-reported acceptability, clinical confidence, self-reported long-term symptoms, and health and quality of life outcomes over 12 months follow-up. Findings will provide definitive evidence for whether simplified and accessible multi-night testing can improve accuracy and cost-effectiveness of OSA diagnosis in routine care.


  • Open Access

    Bidirectional associations between sleep and physical activity investigated using large-scale objective monitoring data

    by Josh Fitton, Duc Phuc Nguyen, Bastien Lechat, Hannah Scott, Barbara Toson, Jack Manners, Claire Dunbar, Kelly Sansom, Lucia Pinilla, Anna Hudson, et al.

    Background The extent to which people routinely co-attain recommended sleep and physical activity levels, as well as bidirectional associations between both health behaviours, are poorly understood at the global level. This study aimed to describe the routine co-attainment of adequate sleep and daily step count thresholds and investigate non-linear associations between objective sleep and daily step count in a large multi-national sample of objective health monitoring data. Methods Data were collected from 70,963 users of two consumer-available health devices—an under-mattress sleep sensor and wrist-worn health tracker—between January 2020 and September 2023. Generalised additive models were used to investigate potentially non-linear, bidirectional, exposure-response relationships between sleep parameters (sleep duration, sleep efficiency, and sleep onset latency) and step count at the next-day/night level. Subgroup analyses were undertaken to investigate age-related differences in all effects. Results We show that only 12.9% of people achieve the recommended sleep duration of 7-9hrs/night and >8,000 steps/day, with 16.5% having short sleep (<7hrs/night) and sedentary lives (<5,000 steps/day). Approximately 6hrs sleep equates to the greatest next-day step count (e.g., +339 steps vs 8 hrs/night), and sleep efficiency positively predicts next-day step count in a dose-dependent manner (25th vs 75th percentile: +282 steps/day). Sleep appears largely unaffected by previous-day step count. Effects are similar across age groups but decline in magnitude when adjusted for ‘awake duration’. Conclusions Our findings provide insight into the bidirectional relationship between sleep-activity globally and highlight the need to ensure sleep and activity health recommendations are mutually attainable.


  • Open Access

    “Social Apnea”: Obstructive Sleep Apnea Is Exacerbated on Weekends

    by Lucía Pinilla, Bastien Lechat, Hannah Scott, Amy C. Reynolds, Jack Manners, Kelly Sansom, Robert Adams, Pierre Escourrou, Peter Catcheside, Danny J. Eckert


  • Open Access

    Rising prevalence of obstructive sleep apnoea during night-time heatwaves across Europe

    by Lucía Pinilla, Josh Fitton, Nicole Lovato, Barbara Toson, Pierre Escourrou, Danny J. Eckert, Bastien Lechat

    Recent data indicate that chronic exposure to elevated ambient temperatures is associated with increased severity of obstructive sleep apnoea (OSA). As global temperatures continue to rise, warming-driven increases in OSA prevalence are projected to further exacerbate the burden of disease, with significant personal, societal, and economic consequences [1]. Alongside rising temperatures, climate change is critically increasing the frequency, intensity and duration of extreme weather events (e.g. heatwaves), with Europe being one of the most vulnerable regions [2]. However, the effects of acute extreme heat exposure on OSA severity remains largely unexplored. In this large-scale, real-world, multinational study, we demonstrate an increase in OSA prevalence of 1.12% (95% CI 1.05–1.19%) for every 1 °C rise in night-time temperature during European summer heatwaves.


  • Top Cited Papers

    Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis

    by Ali Azarbarzin, Daniel Vena, Neda Esmaeili, Andrew Wellman, Lucía Pinilla, Ludovico Messineo, Andrey Zinchuk, Raichel Alex, Mathias Baumert, Kelly A Loffler, et al.

    Background and Aims: Randomized trials of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) in patients with cardiovascular disease have not detected reduced risk of major adverse cardiovascular and cerebrovascular events (MACCEs). This study tested whether the cardiovascular benefit of CPAP occurs preferentially in high-risk OSA, characterized by greater OSA-related heart rate acceleration or hypoxaemia. Methods: In a post hoc analysis of pooled Randomized Intervention with Continuous Positive Airway Pressure in Coronary Artery Disease and Obstructive Sleep Apnoea, Impact of Continuous Positive Airway Pressure on Patients with Acute Coronary Syndrome and Nonsleepy Obstructive Sleep Apnoea, and Sleep Apnoea Cardiovascular Endpoints Study randomized trials; outcomes were stratified by high-risk OSA status, defined by heart rate response following OSA respiratory events >9.4 b.p.m. (third tertile) or oxygen desaturation area under baseline (hypoxic burden) > 87.1% min/h (third tertile). Cox mixed models quantified the CPAP treatment effect on MACCE (including cardiovascular mortality, myocardial infarction, and stroke) within high-risk OSA and the difference vs low-risk status (primary test). Secondary analyses examined participants without excessive sleepiness (Epworth <11 points) or without increased blood pressure (systolic/diastolic <140/90 mmHg). Results: In 3549 participants, 16.6% and 16.3% reached the MACCE endpoint with CPAP (n = 1778) and usual care (n = 1771), respectively. The CPAP treatment effect was greater in participants with vs without high-risk OSA [interaction hazard ratio (iHR) .69, 95% confidence interval (CI) .50–.95, Pinteraction = .024; Nhigh-risk = 1832]. The differential effect was stronger in those without excessive sleepiness (iHR .59, 95% CI .41–.84; Nhigh-risk = 1509), or without increased blood pressure (iHR .54, 95% CI .36–.81; Nhigh-risk = 1244). Continuous positive airway pressure benefits in high-risk OSA were observed alongside harm in low-risk OSA. Conclusions: Continuous positive airway pressure preferentially improves cardiovascular outcomes in high-risk OSA, while harm in low-risk OSA may counteract this effect. These findings provide a pathway to identify patients likely to benefit.


  • Open Access

    Obstructive sleep apnea severity varies by season and environmental influences such as ambient temperature

    by Bastien Lechat, Duc Phuc Nguyen, Kelly Sansom, Lucia Pinilla, Hannah Scott, Amy C. Reynolds, Andrew Vakulin, Jack Manners, Robert J. Adams, Jean-Louis Pepin, et al.

    Background: Obstructive sleep apnea (OSA) severity often varies considerably from night-to-night, but whether environmental factors play a role is unclear. This study investigated seasonal and temperature-related changes in OSA severity. Methods: Data were acquired from 70,052 participants with an average apnea-hypopnea index (AHI) ≥ 5 events/hour who used an under-mattress sleep sensor at least 4 times/week between January 2020 and September 2023. Fixed effect models were used to investigate the association between AHI and day of the year, adjusting for geographical location, variation in total sleep time, ambient temperature, and air pollution. Results: Participants are middle-aged (mean ± SD, 53 ± 13 years), predominantly male (81%), overweight (BMI; 29 ± 6 kg/m2) and have an average of 492 ± 341 nights of data. Mean AHI is 18.0 ± 14.0 events/h and within-subject coefficient of variation is ±51%. AHI is ~5% higher during summer/winter compared to spring/autumn in the northern hemisphere, and 10–15% higher during summer compared to spring in the southern hemisphere. Higher ambient temperature (25th vs. 75th percentiles; 6 vs. 18 degrees Celsius) is associated with a 6.4% (95% CI; 6.3–6.5) increase in AHI. Results are consistent across 23 countries, although the effect of temperature on AHI is larger in Europe vs. the United States or Australia. Conclusions: Here we demonstrate a seasonal component to OSA severity, partially explained by ambient temperature and seasonal variation in sleep duration. Our findings highlight the need to report data collection months in OSA clinical trials, and further study to uncover the physiology behind seasonal variation in OSA severity are required.


  • Top Cited Papers
    Open Access

    Global warming may increase the burden of obstructive sleep apnea

    by Bastien Lechat, Jack Manners, Lucía Pinilla, Amy C. Reynolds, Hannah Scott, Daniel Vena, Sebastien Bailly, Josh Fitton, Barbara Toson, Billingsley Kaambwa, et al.

    High ambient temperatures are associated with reduced sleep duration and quality, but effects on obstructive sleep apnea (OSA) severity are unknown. Here we quantify the effect of 24 h ambient temperature on nightly OSA severity in 116,620 users of a Food and Drug Administration-cleared nearable over 3.5 years. Wellbeing and productivity OSA burden for different levels of global warming were estimated. Globally, higher temperatures (99th vs. 25th; 27.3 vs. 6.4 °C) were associated with a 45% higher probability of having OSA on a given night (mean [95% confidence interval]; 1.45 [1.44, 1.47]). Warming-related increase in OSA prevalence in 2023 was estimated to be associated with a loss of 788,198 (489,226, 1,087,170) healthy life years (in 29 countries), and a workplace productivity loss of 30 (21 to 40) billion United States dollars. Scenarios with projected temperatures ≥1.8 °C above pre-industrial levels would incur a further 1.2 to 3-fold increase in OSA burden by 2100.